New Delhi, India (PressExposure) July 20, 2009 -- CSC (NYSE: CSC) announced that it has signed a seven-year information technology (IT) services outsourcing contract with dental implant manufacturer Nobel Biocare headquartered in Switzerland. Financial terms of the agreement were not disclosed.
CSC will assume responsibility for desktop and help desk services, as well as data center operations supporting 38 Nobel Biocare locations in 33 countries representing five continents. Outsourcing these functions will enable the company to achieve cost savings starting in the first year and supports Nobel Biocare's strategy to increase profitability and ensure long-term growth.
"Signing this agreement demonstrates the confidence industry leaders like Nobel Biocare have in our ability to provide flexible, cost-effective solutions that meet evolving business needs," said Gerhard Fercho, president of CSC's Central European Region. "We are pleased to add Nobel Biocare to our roster of Swiss clients and our growing list of healthcare companies around the globe."
About Nobel Biocare
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its key brands NobelActive(TM), Branemark System(R), NobelReplace(TM), NobelSpeedy(TM), Replace Select (dental implants), NobelProcera(TM) (individualized dental prosthetics), NobelGuide(TM) (complete patient rehabilitation program) and NobelSmile(TM) (patient education and awareness program). Nobel Biocare is a full solution provider for restorative esthetic dentistry, offering a wide range of innovative Crown & Bridge & Implant products, as well as training and education, patient information and clinically documented treatment concepts. Nobel Biocare has over 2,400 employees and recorded revenue of EUR 619.2 million in 2008. The Company is domiciled and headquartered in Zurich, Switzerland. Production takes place at six production sites located in Sweden, the US, Japan and Israel. Nobel Biocare has 37 direct sales organizations. The shares of the parent company Nobel Biocare Holding AG are listed on the SIX Swiss Exchange.